Monday, April 10, 2023 9:02:42 AM
The future of the global economy lies in artificial intelligence, and according to Entrepreneur magazine, AI is expected to be one of the fastest-growing industries of 2023—already valued at $328.34 billion. Trend Innovations’ acquisition is ideally timed given the rockstar status that artificial intelligence is enjoying worldwide combined with the explosive growth rate of the market(s) in which Trend Innovations will now be competing. According to Precedence Research, the size of the global AI software market was $138.4 billion in 2022, and it is expected to surpass $1.1 trillion by 2032. The research firm added that the market is poised to grow at a compound annual growth rate (CAGR) of 22.97% from 2023 to 2032.
Recent AVAI News
- Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells • PR Newswire (US) • 04/10/2026 01:55:00 PM
- The Credibility Filter Wall Street Uses to Sort Biotech Winners • GlobeNewswire Inc. • 04/08/2026 01:15:00 PM
- Avaí Bio and Austrianova to Present Latest Data on Klotho Anti-Aging Therapy at Annual Klotho Conference • PR Newswire (US) • 04/07/2026 12:00:00 PM
- The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step • PR Newswire (US) • 04/01/2026 12:49:00 AM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (US) • 03/24/2026 03:05:00 PM
- Advanced Cell-based Therapy Booming the Success for Healthcare Sector • PR Newswire (US) • 03/24/2026 02:00:00 PM
- The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed • GlobeNewswire Inc. • 03/18/2026 03:30:00 PM
- A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. • PR Newswire (US) • 03/18/2026 02:00:00 PM
- Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them • PR Newswire (US) • 03/03/2026 03:02:00 PM
- Avaí Bio and Austrianova Begin Production of Master Cell Bank for Klotho Anti-Aging Therapy Under GMP Standards • PR Newswire (US) • 03/03/2026 01:30:00 PM
- 5 Stocks Sitting on the Right Side of the Biggest Repricing in a Generation • GlobeNewswire Inc. • 02/18/2026 03:21:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2026 09:20:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 01:52:27 PM
- 5 Assets Securing the 2026 Sovereign Stack • GlobeNewswire Inc. • 01/26/2026 03:13:47 PM
- Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets • GlobeNewswire Inc. • 01/23/2026 05:56:22 PM
- 5 Stocks Securing the 2026 Choke Points • GlobeNewswire Inc. • 01/14/2026 03:15:00 PM
- 5 Assets Anchoring the Next Industrial Cycle • GlobeNewswire Inc. • 12/17/2025 03:21:18 PM
- From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes • GlobeNewswire Inc. • 12/16/2025 05:00:04 PM
- 5 Companies Solving the Invisible Crisis • GlobeNewswire Inc. • 12/15/2025 03:54:35 PM
- Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival • InvestorsHub NewsWire • 12/09/2025 01:00:00 PM
- 5 Stocks Anchoring the New Economy • GlobeNewswire Inc. • 12/08/2025 02:12:18 PM
- 5 Market Anomalies Trading Below Reality • GlobeNewswire Inc. • 12/06/2025 06:51:21 PM
- The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care • GlobeNewswire Inc. • 11/19/2025 03:06:39 PM
- Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies • InvestorsHub NewsWire • 11/18/2025 03:41:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 11:11:24 AM
